The Global Infertility Services Market was valued at USD 7.19 Billion in 2023 and is projected to reach USD 13.67 Billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period (2024-2032). This expansion reflects increasing reproductive health challenges, technological advancements in assisted reproduction, and greater societal acceptance of fertility treatments worldwide.
With delayed parenthood trends and rising infertility rates across developed economies, the demand for advanced fertility solutions continues to accelerate. This report profiles the Top 10 Companies in the Infertility Services Industry – pharmaceutical innovators, clinical service providers, and medical technology leaders who are redefining fertility care through scientific breakthroughs and patient-centered solutions.
🔟 1. Ferring Pharmaceuticals
Headquarters: Saint-Prex, Switzerland
Key Offering: Reproductive medicines, Fertility hormones
A pioneer in reproductive medicine, Ferring develops innovative treatments for infertility including recombinant gonadotropins and ovulation triggers used in ART procedures globally.
Key Developments:
- World’s first recombinant hCG (human chorionic gonadotropin)
- Next-gen FSH (follicle-stimulating hormone) formulations
- Global fertility education initiatives reaching 60+ countries
Download FREE Sample Report: Infertility Services Market – View in Detailed Research Report
9️⃣ 2. Merck KGaA
Headquarters: Darmstadt, Germany
Key Offering: Fertility drugs, IVF lab technologies
Merck’s fertility division provides a comprehensive portfolio of gonadotropins for ovarian stimulation and advanced media/technologies supporting IVF laboratories.
Key Developments:
- Market-leading recombinant FSH products
- Innovative embryo culture systems
- Digital platforms for fertility clinic management
8️⃣ 3. Vitrolife
Headquarters: Gothenburg, Sweden
Key Offering: IVF culture media, Cryopreservation solutions
As a global leader in IVF media systems, Vitrolife provides essential products for embryo development including time-lapse incubators and vitrification solutions.
Key Developments:
- Proprietary embryo culture media formulations
- Strategic acquisitions expanding product portfolio
- Quality control systems for ART laboratories
7️⃣ 4. Irvine Scientific
Headquarters: Santa Ana, California, USA
Key Offering: ART media, Cryopreservation technologies
Now part of FUJIFILM Holdings, Irvine Scientific develops high-performance culture media and supplements for assisted reproductive technologies.
Key Developments:
- Single-step culture media systems
- Specialized media for PGS/PGD procedures
- Global expansion in emerging fertility markets
Download FREE Sample Report: Infertility Services Market – View in Detailed Research Report
6️⃣ 5. CooperSurgical
Headquarters: Trumbull, Connecticut, USA
Key Offering: IVF lab equipment, Genetic testing
CooperSurgical offers an extensive portfolio of IVF lab instruments ranging from incubators to micromanipulation systems and preimplantation genetic screening solutions.
Key Developments:
- Time-lapse embryo imaging systems
- Comprehensive PGT solutions
- Workflow optimization technologies
5️⃣ 6. Monash IVF
Headquarters: Melbourne, Australia
Key Offering: Full-service fertility clinics, Genetic services
With historical roots in the world’s first IVF pregnancy, Monash IVF operates a growing network of fertility centers across Australia and Asia with consistently high success rates.
Key Developments:
- Pioneering vitrification techniques
- Expanding telehealth fertility services
- Innovative embryo selection technologies
4️⃣ 7. Virtus Health
Headquarters: Melbourne, Australia
Key Offering: Fertility treatments, Donor programs
Virtus Health operates one of Asia-Pacific’s largest fertility service networks, performing over 6,000 ART cycles annually across multiple countries.
Key Developments:
- AI applications in embryo assessment
- International clinic expansion strategy
- Comprehensive donor egg/sperm programs
3️⃣ 8. INVO Bioscience
Headquarters: Medford, Massachusetts, USA
Key Offering: INVOcell technology, Affordable IVF
INVO Bioscience specializes in accessible fertility solutions through its innovative INVOcell device that enables IVF incubation within the patient’s body.
Key Developments:
- Disruptive intravaginal culture technology
- Global partnerships expanding access
- Cost-effective fertility treatment model
Download FREE Sample Report: Infertility Services Market – View in Detailed Research Report
2️⃣ 9. Abbott
Headquarters: Abbott Park, Illinois, USA
Key Offering: Fertility diagnostics, Hormone tests
Abbott provides essential diagnostic systems for fertility assessment including quantitative hormone analyzers and ovarian reserve testing.
Key Developments:
- Automated hormone testing platforms
- At-home fertility testing innovations
- Reproductive health research collaborations
1️⃣ 10. Theramex
Headquarters: London, United Kingdom
Key Offering: Fertility medications, Hormone therapies
Specializing in women’s health, Theramex provides essential fertility drugs including gonadotropins and ovulation stimulants for ART procedures.
Key Developments:
- Specialized fertility drug portfolio
- Patient support and education programs
- Global access initiatives
Get Full Report Here: Infertility Services Market – View in Detailed Research Report
🌍 Outlook: Personalized and Accessible Fertility Solutions Are Shaping the Future
The infertility services landscape is undergoing transformation as technological innovations and changing societal attitudes redefine reproductive healthcare.
📈 Emerging Market Trends:
- Increasing adoption of time-lapse embryo imaging
- Growth of fertility preservation services
- AI applications in embryo selection and treatment planning
- Expanding insurance coverage for fertility treatments
- Rising demand in emerging markets
These industry leaders are not only creating families – they’re advancing the frontiers of reproductive science worldwide.